Mycophenolate Mofetil

Cat. No S57C4X-15155_10_MG

Vendor: US-CATO

Product Information

Product Name

Brand Name

US-CATO

Product Number

C4X-15155

CAS

128794-94-5

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

5281078

IUPAC Name

2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate

InChI Key

RTGDFNSFWBGLEC-SYZQJQIISA-N

SMILES

CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O

References

[Annual report 2025 from the National Database of the Regional Collaborative Rheumatology Centers in Germany]

Publication Name: Zeitschrift fur Rheumatologie

Publication Date: 2025-11

DOI: 10.1007/s00393-025-01646-8

[Severe late-onset neutropenia after rituximab administration]

Publication Name: Zeitschrift fur Rheumatologie

Publication Date: 2025-10

DOI: 10.1007/s00393-025-01668-2

[Treatment of neuroimmunological diseases with chimeric antigen receptor (CAR) T cells : Experience and new developments]

Publication Name: Zeitschrift fur Rheumatologie

Publication Date: 2025-10

DOI: 10.1007/s00393-025-01676-2

[Obinutuzumab in lupus nephritis: success with effective B cell depletion]

Publication Name: Zeitschrift fur Rheumatologie

Publication Date: 2025-09

DOI: 10.1007/s00393-025-01671-7

Applying exposure-response analysis to enhance Mycophenolate Mofetil dosing precision in pediatric patients with immune-mediated renal diseases by machine learning models

Publication Name: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Publication Date: 2025-08-01

DOI: 10.1016/j.ejps.2025.107146

Mycophenolate Mofetil

Product Information

General Information

References

[Annual report 2025 from the National Database of the Regional Collaborative Rheumatology Centers in Germany]

[Severe late-onset neutropenia after rituximab administration]

[Treatment of neuroimmunological diseases with chimeric antigen receptor (CAR) T cells : Experience and new developments]

[Obinutuzumab in lupus nephritis: success with effective B cell depletion]

Applying exposure-response analysis to enhance Mycophenolate Mofetil dosing precision in pediatric patients with immune-mediated renal diseases by machine learning models